Medical Progress Today
mpt home | sign up

Volume 3, Number 18
May 19, 2006


PRINTER FRIENDLY

News

FDA panel backs key STD vaccine; Medical community hails 'breakthrough' in cervical cancer fight
Chicago Tribune, 5-19-06

Editor's Notes:

Amidst an ongoing flood of Vioxx litigation, Merck got some badly needed good news—and good press—this week when an FDA advisory panel unanimously recommended approval for its new cervical cancer vaccine. Merck's vaccine could slash cervical cancer rates around the world, particularly in developing nations where there is little access to routine gynecological care.
Continue reading . . .

Commentary

How safe is too safe?
Matthew W. Strobeck, Tomas Philipson, Adrian H. B. Gottschalk, Ernst R. Berndt, Milken Institute Review, 5-19-06

Philipson and his co–authors have adopted a fascinating working paper from the National Bureau of Economic Research that offers a cost–benefit analysis weighing the societal benefits of accelerated drug approval vs. the costs of unsafe drugs potentially being approved by the agency. They conclude that, by any reasonable measure, declines in drug approval times by the agency—and therefore faster access to new medicines—offer vastly more benefits to consumers than costs.
Continue reading . . .

They'd Sooner Fix Medicaid
Tom Coburn, Regina E. Herzlinger, Manhattan Institute, 5-18-06

U.S. Senator Tom Coburn, from Oklahoma, and Regina Herzlinger, a senior fellow at the Manhattan Institute, discuss Medicaid reform efforts in Oklahoma, which are modeled after similar consumer-driven initiatives in Florida and South Carolina.
Continue reading . . .

Evidence Based Health Policy Against Fads
Anders Sandberg, Center for the New Europe, 5-18-06

In this blog post on the CNE health website, Sanders makes a very interesting observation about the persistence of management fads, and how it may afflict the growing movement for "evidence–based medicine":
Continue reading . . .

Death's Waiting List
Sally Satel, MD, The New York Times, 5-15-06

Satel, a beneficiary of a kidney transplant, inveighs against the U.S.'s ineffective—and therefore deadly—system for matching potential kidney donors with the people who need transplants. She concludes that high–handed moralism—rather than a rational analysis of the costs and benefits of the current system–needlessly kills thousands of patients on kidney waiting lists every year.
Continue reading . . .

Try and Try Again
Grace-Marie Turner, Galen Institute, 5-12-06

Turner shares her frustration with two recent votes on health care reform legislation in the U.S. Senate.
Continue reading . . .

Research

Medical Malpractice Awards, Insurance, and Negligence: Which Are Related?
Amanda Agan, Alexander Tabarrok, Manhattan Institute, 5-18-06

Medical malpractice insurance premiums have reached an all-time high. In response, doctors have retired early, shut down their businesses, or reduced the scope of their practices. In this Civil Justice Report, George Mason University's Alexander Tabarrok and Amanda Agan look empirically at the cause of increased medical malpractice
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

NEWS

FDA panel backs key STD vaccine; Medical community hails 'breakthrough' in cervical cancer fight

COMMENTARY

How safe is too safe?
They'd Sooner Fix Medicaid
Evidence Based Health Policy Against Fads
Death's Waiting List
Try and Try Again

RESEARCH

Medical Malpractice Awards, Insurance, and Negligence: Which Are Related?
Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org